Olaf Penack

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (9)

Halvard Bonig

GERMANY

View details

Rosanne Sprute

University Hospital Bonn

GERMANY

View details

Lucie Loyal

Charité - Universitätsmedizin Berlin

GERMANY

View details

Ingo Müller

University Medical Center Hamburg-Eppendorf

GERMANY

View details

Andrea Jarisch

University Hospital

GERMANY

View details

Benedikt Obermayer

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

GERMANY

View details

Johann Ahn

Charité - Universitätsmedizin Berlin

GERMANY

View details

Il‐Kang Na

GERMANY

View details

Lars Bullinger

Charité University Medicine

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olaf Penack

Research Interests

Explore related searches

Contact this professor

Articles (11)

CD19 CAR T cells are an effective therapy for posttransplant relapse in patients with B-lineage ALL: real-world data from Germany.

Single-cell clonal tracking of persistent T-cells in allogeneic hematopoietic stem cell transplantation.

Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.

Risk factors and characteristics influencing humoral response to COVID-19 vaccination in patients after allogeneic stem cell transplantation.

Characterization of the endotheliopathy, innate-immune activation and hemostatic imbalance underlying CAR-T cell toxicities: laboratory tools for an early and differential diagnosis.

Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.

Hematopoietic stem cell boost for persistent neutropenia after CAR T-cell therapy: a GLA/DRST study.

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience.

Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants.

Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting

Collaborators (9)

Halvard Bonig

Rosanne Sprute

Lucie Loyal

Ingo Müller

Andrea Jarisch

Benedikt Obermayer

Johann Ahn

Il‐Kang Na

Lars Bullinger

Make your next move.